Core Scientific- Warrants Tranche 2 (23/01/2029) Accounts Payable

Core Scientific- Warrants Tranche 2 (23/01/2029) posts a accounts payable of $110M as of June 2026. That compares with $220M in the prior-year period — down 47.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Core Scientific- Warrants Tranche 2 (23/01/2029)'s accounts payable was $220M. The latest reading is $110M — a 47.7% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Accounts Payable is one piece of Core Scientific- Warrants Tranche 2 (23/01/2029)'s financial statement story. At $110M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CORZZ's accounts payable usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Core Scientific- Warrants Tranche 2 (23/01/2029)'s other metric pages and overview cover the third.

Judging Core Scientific- Warrants Tranche 2 (23/01/2029) against Technology peers is usually better than using a market-wide rule of thumb. Business models inside Technology are more comparable, which makes gaps in accounts payable easier to interpret. Start with $110M here, then scan peer and history charts to see if the gap is persistent.